Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Quick Stats
Feb 02, 202659.5
AI Score
HOLD0.77
Volume Ratio
Feb 26, 2026
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
LGND Stock Summary
Last updated Feb 02, 2026
LGND is currently trading at $197.93, positioned above its 200-day moving average of $157.24, indicating a long-term uptrend. The stock has a 52-week range of $93.58 to $212.49.
Technical Analysis: The 50-day moving average stands at $195.93, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 51.824, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.153, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates LGND at 59.5/100 with a HOLD recommendation.
LGND (Ligand Pharmaceuticals Inc.) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 51.824 |
| CMF (20) | 0.153 |
| ROC (10) | 2.57 |
| ADX (14) | 17.185 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.095 |
| AROONOSC (14) | -7.143 |
| WILLAMS %R (14) | -29.291 |
| MFI (14) | 45.274 |
LGND Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
LGND Price vs Max Options Open Interest
LGND Max Change In Options Open Interest
LGND Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LGND Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LGND Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LGND Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Ligand Pharmaceuticals Inc. is above both 50 Day and 200 Day SMA which is considered Bullish.
LGND Moving Averages Analysis
Ligand Pharmaceuticals Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Feb 02, 2026
Ligand Pharmaceuticals Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026
LGND (Ligand Pharmaceuticals Inc.) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 196.99 |
| 20 | 197.29 |
| 30 | 196.61 |
| 50 | 195.93 |
| 100 | 189.72 |
| 200 | 157.24 |
LGND Fundamental Analysis
| P/E (Forward) | 23.0947 |
| P/E (Trailing) | 84.6256 |
| Market Cap ($) | 3.8 billion |
| Earnings/Share ($) | 2.27 |
| Net Proft Margin (%) | 0.1934 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 7.58 |
| EPS Estimate Next Year ($) | 8.4157 |
| WallStreet Target Price ($) | 243.4444 |
| Most Recent Quarter |